The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study

OBJECTIVE: To assess the efficacy and safety of the novel histone deacetylase inhibitor, chidamide, in combination with cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone (Chi-CHOEP) for untreated peripheral T-cell lymphoma (PTCL). METHODS: A prospective, multicenter, single arm,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Su, Liping, Liu, Lihong, Gao, Yuhuan, Wang, Quanshun, Su, Hang, Song, Yuhuan, Zhang, Huilai, Shen, Jing, Jing, Hongmei, Wang, Shuye, Cen, Xinan, Liu, Hui, Liu, Aichun, Li, Zengjun, Luo, Jianmin, He, Jianxia, Wang, Jingwen, O’Connor, O. A., Zhou, Daobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330529/
https://www.ncbi.nlm.nih.gov/pubmed/33755379
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330529/
https://www.ncbi.nlm.nih.gov/pubmed/33755379
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0413

Ejemplares similares